Growth Metrics

Boston Scientific (BSX) Change in Cash (2016 - 2026)

Boston Scientific's Change in Cash history spans 18 years, with the latest figure at -$504.0 million for Q1 2026.

  • On a quarterly basis, Change in Cash fell 260.51% to -$504.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $723.0 million, a 145.85% increase, with the full-year FY2025 number at $1.5 billion, up 442.44% from a year prior.
  • Change in Cash hit -$504.0 million in Q1 2026 for Boston Scientific, down from $671.0 million in the prior quarter.
  • Over the last five years, Change in Cash for BSX hit a ceiling of $1.4 billion in Q1 2024 and a floor of -$2.0 billion in Q4 2024.
  • Historically, Change in Cash has averaged -$30.9 million across 5 years, with a median of -$71.0 million in 2022.
  • Biggest five-year swings in Change in Cash: skyrocketed 6888.89% in 2022 and later tumbled 2554.55% in 2024.
  • Tracing BSX's Change in Cash over 5 years: stood at $629.0 million in 2022, then tumbled by 112.24% to -$77.0 million in 2023, then tumbled by 2554.55% to -$2.0 billion in 2024, then skyrocketed by 132.83% to $671.0 million in 2025, then tumbled by 175.11% to -$504.0 million in 2026.
  • Business Quant data shows Change in Cash for BSX at -$504.0 million in Q1 2026, $671.0 million in Q4 2025, and $735.0 million in Q3 2025.